America
New treatment offers hope for treating diabetes, MS
New York, March 5
Researchers have developed a novel and safe treatment for autoimmune diseases including Type-1 diabetes and multiple sclerosis (MS) that arise when the body's immune cells attack itself.
Current treatments eliminate these misfunctioning immune cells, but also destroy normal, protective immune cells, leaving patients susceptible to immune deficiency and opportunistic infections.
The new approach, by researchers from the University of Utah in the US, targets the misfunctioning immune cells while leaving the normal immune cells in place.
In the study, published in the journal Nature Biomedical Engineering, the team engineered a protein molecule to deplete the misfunctioning PD-1-expressing cells from the body while leaving normal immune cells in place.
"We wanted to target PD-1-expressing cells. Using this method, we may avoid long-term immune deficiency caused by common treatments for autoimmune disease," said lead author Peng Zhao, from the varsity.
When tested in a mouse model mimicking Type-1 diabetes, the treatment delayed the onset of diabetes.
"We are really taking treatment for the autoimmune disease in a new direction," said Mingnan Chen, Assistant Professor at the varsity.
"To make similar therapeutics for people, we would need to find the anti-human PD-1 antibody, like the anti-mouse PD-1 antibody.
"If we can generate the human version of therapeutics, I think we could make a huge impact in treating autoimmune disease," Chen said.
In addition, the treatment was also applied to a mouse MS model.
Besides halting the progression of paralysis, the treatment also restored the mice's ability to walk.
In a normal functioning immune system, the PD-1-expressing cells, including immune cells, contain a mechanism that prevents the cycle from attacking itself.
However, in people with autoimmune disease, these cells somehow escape the checkpoint and the immune system remains in a state of alert, attacking body cells.
Current treatments eliminate these misfunctioning immune cells, but also destroy normal, protective immune cells, leaving patients susceptible to immune deficiency and opportunistic infections.
The new approach, by researchers from the University of Utah in the US, targets the misfunctioning immune cells while leaving the normal immune cells in place.
In the study, published in the journal Nature Biomedical Engineering, the team engineered a protein molecule to deplete the misfunctioning PD-1-expressing cells from the body while leaving normal immune cells in place.
"We wanted to target PD-1-expressing cells. Using this method, we may avoid long-term immune deficiency caused by common treatments for autoimmune disease," said lead author Peng Zhao, from the varsity.
When tested in a mouse model mimicking Type-1 diabetes, the treatment delayed the onset of diabetes.
"We are really taking treatment for the autoimmune disease in a new direction," said Mingnan Chen, Assistant Professor at the varsity.
"To make similar therapeutics for people, we would need to find the anti-human PD-1 antibody, like the anti-mouse PD-1 antibody.
"If we can generate the human version of therapeutics, I think we could make a huge impact in treating autoimmune disease," Chen said.
In addition, the treatment was also applied to a mouse MS model.
Besides halting the progression of paralysis, the treatment also restored the mice's ability to walk.
In a normal functioning immune system, the PD-1-expressing cells, including immune cells, contain a mechanism that prevents the cycle from attacking itself.
However, in people with autoimmune disease, these cells somehow escape the checkpoint and the immune system remains in a state of alert, attacking body cells.
5 hours ago
South Asians face double the risk of heart attack; 'It's the numbers, not the symptoms, that matter'; Dr. Sherin Abraham.
9 hours ago
“Serve Others through Sewa and Find Meaning in Life,” Seniors Urged at Diwali Event in Houston
9 hours ago
Russia calls claims of rejecting US peace plan for Ukraine as 'incorrect'
9 hours ago
Balochistan insurgency driven by marginalisation and repression by Pakistan: Report
10 hours ago
Talks 'constructive,' yet 'no compromise' reached in Russia-US push for Ukraine peace
16 hours ago
THE GREEN ALERT- Docu Drama: An appraisal by Experts
16 hours ago
US Senator proposes ending dual citizenship citing "divided loyalties"
16 hours ago
US to strike "very soon" inside Venezuela in action against drug traffickers: Trump
16 hours ago
Trump declares all Biden autopen-signed documents, including pardons "null and void"
16 hours ago
Sexual assault case: Court reserves order on Cong MLA Mamkootathil's anticipatory bail plea
17 hours ago
Yami Gautam says 'good cinema shall win' as she thanks the audience for all the love showered on 'HAQ'
17 hours ago
Michelle Pfeiffer: Moms are unsung heroes of their families
17 hours ago
Armaan Malik says 'trust' shaped the heart of 'Chal Musafir' from 'Gustaakh Ishq'
